Pump Science
A decentralized platform crowdfunding anti-aging research via tokens
Performances
RD Popularity Index
RD Growth Index
Comparison
Follow Updates
Follow Lists
People
About Pump Science
Pump Science is a Solana DeSci platform from Molecule and BIO Protocol that ties real longevity experiments to tradable tokens: each compound has a token, a bonding curve raises funds, seventy percent of trading fees fund the study, and liquidity migrates to Meteora once a market-cap threshold is met.
It targets scarce funding and opaque grant decisions for basic research, publishing data progressively from worms and flies to mice and humans, with token holders holding corresponding IP and commercial revenue shares. In February 2026 the presale for compound EGS refunded 91.87 percent of commitments, a record for such launches, after which the platform moved to combination compounds and a supplement store presale. Token prices track experimental results, so one negative readout hits the next raise directly.
Pump Science opened its e-commerce store in 2026 and launched the first tokenized supplement, Urolithin A, available for preorder, closing the loop from on-chain research to physical products. The community approved the ISO concept, and the RODeo prediction market went live, with proceeds funding RIF and URO buyback and burn.
Pump Science's tokenomics design is complete, using a custom bonding curve (5000 USD initial market cap), liquidity migration to Meteora, and LP fees recycling into research. BIO airdropped to RIF and URO holders.
Future strategy and roadmap: Going forward, Pump Science plans more compound token launches, advances to human trials, and deploys an AI trading bot acting on experimental data, expanding its DeSci physical-product lineup.
Benji Leibowitz — Founder; leads the drug IP and data tokenization model.
Paul Kohlhaas — Co-founder & CEO of Molecule, which incubated Pump Science.
Tyler Golato — Co-founder of Molecule.